601 studies found for:
EGF
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF
|
||||
| 2 | Recruiting |
EGF Ointment for Erlotinib Skin Lesion
|
||||
| 3 | Completed |
Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma
|
||||
| 4 | Completed |
Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis
|
||||
| 5 |
Completed
Has Results |
Evaluating ABX-EGF is the Same as "Panitumumab" in Patients With Metastatic Colorectal Cancer
|
||||
| 6 |
Completed
Has Results |
Evaluating ABX-EGF (Panitumumab) Monotherapy in Subjects With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
|
||||
| 7 | Active, not recruiting |
A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients
|
||||
| 8 |
Completed
Has Results |
Effect of EGF With Silver Sulfadiazine Cream Compared With Silver Zinc Sulfadiazine Cream for Treatment of Burn Wound
|
||||
| 9 | Completed |
ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
|
||||
| 10 | Completed |
Evaluating ABX-EGF Plus Best Supportive Care Versus Best Supportive Care in Subjects withMetastatic Colorectal Cancer
|
||||
| 11 | Completed |
Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors
|
||||
| 12 | Completed |
ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
|
||||
| 13 | Completed |
Laryngeal and Esophageal EGF-r Expression in Patients With Reflux Laryngitis
|
||||
| 14 | Completed |
Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer
|
||||
| 15 | Completed |
Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer
|
||||
| 16 | Completed |
ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body
|
||||
| 17 | Completed |
ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
|
||||
| 18 | Completed |
Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis
|
||||
| 19 | Active, not recruiting |
Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
|
||||
| 20 | Active, not recruiting |
Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients
|
† Indicates status has not been verified in more than two years
